Dr. Reddy's Laboratories Celebrates 25 Years of NYSE Listing with Closing Bell Ceremony

Dr. Reddy's Laboratories Celebrates 25 Years on New York Stock Exchange

Dr. Reddy's Laboratories marked a significant milestone on Friday, commemorating 25 years of its listing on the New York Stock Exchange (NYSE). The occasion, which underscored the company's global growth journey and long-standing presence in the US market, was celebrated with a closing bell ceremony at the iconic NYSE trading floor in New York.

Chairman Satish Reddy and senior members of the leadership team led the ceremony, which was attended by several top executives and board members, including Chief Executive Officer Erez Israeli, CEO-Global Generics M. V. Ramana, Chief Financial Officer M. V. Narasimham, and North America CEO Milan Kalawadia.

The company's listing on the NYSE in April 2001 marked a significant milestone in its history, making Dr. Reddy's the first pharmaceutical company from Asia outside Japan to be listed on the exchange. This achievement was a testament to the company's commitment to global governance, transparency, and innovation.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Reflecting on the occasion, Satish Reddy highlighted the significance of the milestone, stating that it represented more than just a market listing. He paid tribute to the vision of the company's founder, K. Anji Reddy, who had a simple yet powerful mission: to make affordable and innovative medicines accessible to patients worldwide. Satish Reddy noted that this vision had driven the company's NYSE debut in 2001 and continues to shape its identity today.

As the company looks ahead, Satish Reddy emphasized its unwavering commitment to accelerating access to affordable and innovative healthcare. He dedicated the silver jubilee milestone to employees, partners, and shareholders, acknowledging their hard work and dedication to the company's mission.

The NYSE opening and closing bell ceremonies are traditionally held to mark the start and end of daily trading, with companies invited to participate on special milestones and landmark occasions. Dr. Reddy's Laboratories' 25-year listing on the NYSE is a testament to its enduring presence in the US market and its commitment to global governance, transparency, and innovation.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data